Proton therapy used to be an area of niche research and a very expensive way to treat cancer. It is now increasingly moving into the mainstream, and becoming a key part of the arsenal to fight cancer.
Our global survey of 1,000 issuers and 1,000 investors reveals that sustainable investing is becoming mainstream and shows how the effects of COVID-19 are changing attitudes amongst market participants.